Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

LifeStance Health Gr Q4 2024 GAAP EPS $(0.01) Beats $(0.04) Estimate, Sales $325.50M Beat $313.72M Estimate

Author: Benzinga Newsdesk | February 27, 2025 06:04am
LifeStance Health Gr (NASDAQ:LFST) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.04) by 75 percent. This is a 91.67 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $325.50 million which beat the analyst consensus estimate of $313.72 million by 3.75 percent. This is a 16.00 percent increase over sales of $280.60 million the same period last year.

Posted In: LFST


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist